PKG and PKC Are Down-Regulated during Cardiomyocyte Differentiation from Embryonic Stem Cells: Manipulation of These Pathways Enhances Cardiomyocyte Production

Table 2

Significance comparing treated groups to controls (for data points in Figure 3(b)) number beating areas. NS: no significance.

DT-3 compared to controls
Day 12: NS	Day 13: NS	Day 14: NS	Day 15: NS	Day 16: $P<.006$	Day 17: $P<.001$
DT-3 + PKC$\zeta$ inhibitor compared to controls
Day 12: NS	Day 13: $P<.0001$	Day 14: $P<.0001$	Day 15: $P<.0006$	Day 16: $P<.006$	Day 17: $P<.02$
DT-3 + PKCβ inhibitor compared to controls
Day 12: NS	Day 13: NS	Day 14: $P<.02$	Day 15: $P<.02$	Day 16: $P<.001$	Day 17: $P<.02$